Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 103 Lung Neoplasms 44 Breast Neoplasms 41 Triple Negative Breast Neoplasms 34 Ovarian Neoplasms 28 Small Cell Lung Carcinoma 26 Squamous Cell Carcinoma of Head and Neck 23 Fallopian Tube Neoplasms 18 Endometrial Neoplasms 17 Neoplasms 16 Neoplasm Metastasis 13 Head and Neck Neoplasms 13 Uterine Cervical Neoplasms 12 Esophageal Squamous Cell Carcinoma 12 Prostatic Neoplasms 10 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Esophageal Neoplasms 10 Colorectal Neoplasms 9 Recurrence 8 Carcinoma, Transitional Cell 8 Oropharyngeal Neoplasms 7 Carcinoma, Squamous Cell 7 Neuroblastoma 6 Carcinoma, Ovarian Epithelial 6 Urinary Bladder Neoplasms 5 Mesothelioma 5 Lymphoma, Large B-Cell, Diffuse 5 Lung Diseases 5 Adenocarcinoma of Lung 5 Thoracic Neoplasms 4

Interventions

pertuzumab 1 azeliragon 1 Trastuzumab 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cancer Related Cognitive Decline × Carboplatin × Clear all

NCT05256745 2025-12-24

RAGE

Georgetown University

Phase 1/2 Recruiting

Cancer Related Cognitive Decline

Data powered by HemOnc (CC BY 4.0) Colophon ⚡